Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.

Published

Journal Article

BACKGROUND AND AIMS:Most familial hypercholesterolemia (FH) patients remain undertreated, and it is unclear what role health disparities may play for FH patients in the US. We sought to describe sex and racial/ethnic disparities in a national registry of US FH patients. METHODS:We analyzed data from 3167 adults enrolled in the CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia (CASCADE-FH) registry. Logistic regression was used to evaluate for disparities in LDL-C goals and statin use, with adjustments for covariates including age, cardiovascular risk factors, and statin intolerance. RESULTS:In adjusted analyses, women were less likely than men to achieve treated LDL-C of <100 mg/dL (OR 0.68, 95% CI, 0.57-0.82) or ≥50% reduction from pretreatment LDL-C (OR 0.79, 95% CI, 0.65-0.96). Women were less likely than men to receive statin therapy (OR, 0.60, 95% CI, 0.50-0.73) and less likely to receive a high-intensity statin (OR, 0.60, 95% CI, 0.49-0.72). LDL-C goal achievement also varied by race/ethnicity: compared with whites, Asians and blacks were less likely to achieve LDL-C levels <100 mg/dL (Asians, OR, 0.47, 95% CI, 0.24-0.94; blacks, OR, 0.49, 95% CI, 0.32-0.74) or ≥50% reduction from pretreatment LDL-C (Asians, OR 0.56, 95% CI, 0.32-0.98; blacks, OR 0.62, 95% CI, 0.43-0.90). CONCLUSIONS:In a contemporary US population of FH patients, we identified differences in LDL-C goal attainment and statin usage after stratifying the population by either sex or race/ethnicity. Our findings suggest that health disparities contribute to the undertreatment of US FH patients. Increased efforts are warranted to raise awareness of these disparities.

Full Text

Duke Authors

Cited Authors

  • Amrock, SM; Duell, PB; Knickelbine, T; Martin, SS; O'Brien, EC; Watson, KE; Mitri, J; Kindt, I; Shrader, P; Baum, SJ; Hemphill, LC; Ahmed, CD; Andersen, RL; Kullo, IJ; McCann, D; Larry, JA; Murray, MF; Fishberg, R; Guyton, JR; Wilemon, K; Roe, MT; Rader, DJ; Ballantyne, CM; Underberg, JA; Thompson, P; Duffy, D; Linton, MF; Shapiro, MD; Moriarty, PM; Knowles, JW; Ahmad, ZS

Published Date

  • December 2017

Published In

Volume / Issue

  • 267 /

Start / End Page

  • 19 - 26

PubMed ID

  • 29080546

Pubmed Central ID

  • 29080546

Electronic International Standard Serial Number (EISSN)

  • 1879-1484

International Standard Serial Number (ISSN)

  • 0021-9150

Digital Object Identifier (DOI)

  • 10.1016/j.atherosclerosis.2017.10.006

Language

  • eng